Crossmark

Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno‐associated virus capsid and promoter

Published Online: 2014-08-04

Published Print: 2014-09-01

Authors

Cronin, Therese

Vandenberghe, Luk H

Hantz, Péter

Juttner, Josephine

Reimann, Andreas

Kacsó, Ágota–Enikő

Huckfeldt, Rachel M

Busskamp, Volker

Kohler, Hubertus

Lagali, Pamela S

Roska, Botond

Bennett, Jean
Funding

Funding for this research was provided by:

Hope for Vision and the Marie Heim‐Vögtlin

Swiss National Science Foundation

NEI/NIH (8DP1 EY023177)

NEI/NIH (1R24EY019861‐01A1)

Foundation Fighting Blindness

Research to prevent blindness

FM Kirby Foundation
License Information

Text and Data Mining valid from 2014-08-04

Version of Record valid from 2014-08-04
More Information

Article History

Received: 17 March 2014

Revised: 4 July 2014

Accepted: 7 July 2014

First Online: 4 August 2014

Conflict of interest

: TC, LH, and JB are co‐authors on a US patent application for “Enhanced AAV‐mediated gene transfer for retinal therapies”. The other authors declare that they have no conflict of interest.

Document is current